BUY Krishna Institute of Medical Sciences Limited — HSBC Securities
byHSBC SecuritiesHorizon: NA (inferred 1 year)9 Oct 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·8 Oct · yesterday
Krishna Institute of Medical Sciences Ltd will acquire up to 22% equity stake in Splendid Hospitals Private Limited for an aggregate cash consideration of up to Rs 40 crore by way of primary infusion.
BSE · Company Update·6 Oct · 2d ago
Krishna Institute of Medical Sciences Ltd will acquire a 51% equity stake in Sarvottam Health Care Private Limited for up to Rs 80 crore, marking a strategic investment in the Kakinada healthcare mark
BSE · Company Update·6 Oct · 2d ago
Krishna Institute of Medical Sciences Ltd will acquire a 6% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs 15 crore via primary infusion to strengthen its strategic O&M partnership.
BSE · Company Update·6 Oct · 2d ago
The company announced the acquisition of up to 51% stake in Insignia.
BSE · Company Update·6 Oct · 2d ago
Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-ups
NewsEt-Markets·30 Sept · 1w ago
Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 7% on Wednesday
NewsCnbc-Tv18·30 Sept · 1w ago
Apollo, Max Health, Yatharth, KIMS hospital stocks under pressure after SC remarks on drug prices
NewsHbl·30 Sept · 1w ago
Apollo Hospitals, Max Health, Yatharth Hospital, KIMS, other hospital stocks under pressure as SC remarks on drug prices weigh
NewsHbl·30 Sept · 1w ago
Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 6% on Wednesday
NewsCnbc-Tv18·30 Sept · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹831 · SL hit
- BUY — IDBI Capital17 Sept 2026 · ~3 months · target ₹846 · SL hit
- BUY — Investec India10 Sept 2026 · ~1 year · target ₹1,000 · Active
More from HSBC Securities
- BUY Polycab India9 Oct 2026 · ~1 year · target ₹10,250 · Active
- BUY Tata Consultancy Services9 Oct 2026 · ~1 year · target ₹2,350 · Active
- BUY Info Edge (India)9 Oct 2026 · ~1 year · target ₹1,625 · Active
- BUY Rainbow Childrens Medicare9 Oct 2026 · ~1 year · target ₹1,550 · Active
- BUY Fortis Healthcare9 Oct 2026 · ~1 year · target ₹950 · Active

